Document:

Amendment No. 5 dated as of August 9, 2000

 Exhibit 10.48 
  
 Confidential Materials omitted and filed separately with the 
 Securities and Exchange Commission. Asterisks denote omissions. 
  
 MDS Nordion  
 Science Advancing Health
(letterhead) 
  
 December 22, 2004 
  
 Boston Life Sciences Inc. 
 20 Newbury Street 
 Boston, Massachusetts 
 2116 USA 
  
 Dear Sirs: 
  

	Re:	Amendment #4 to Agreement between MDS Nordion Inc. 

 (now MDS Nordion, a division of MDS (Canada) Inc. 
 dated the 9th day of August, 2000 (the “Agreement”) 
  
 Reference is made to the agreement between MDS Nordion Inc. (now MDS Nordion, a division of MDS (Canada) Inc.) and Boston Life Sciences Inc. dated the 9th day of August 2000 (the “Agreement”). 
  
 In consideration of $1.00 and other valuable consideration the sufficiency of which is hereby acknowledged, the parties desire to further
amend the Agreement and extend the term. 
  

	1.	Section 16.1 of the Agreement shall be amended in its entirety and shall read as follows: 

  
 “The term of this Agreement shall commence upon the Effective Date, and unless terminated earlier pursuant to this
Agreement, shall expire on the earlier of (i) FDA granting of BLSI’s NDA with respect to Altropane for Parkinson’s Disease or (ii) December 31, 2005.” 
  

	2.	In addition to the Maximum Batch Size available for purchase as identified in Section 4.1 of the Agreement, BLSI agrees to purchase and MDS Nordion agrees to supply Altropane under
the Agreement in accordance with the terms and Batch size appearing on the face of MDS Nordion’s Quotation 2004-RQ-0400 (attached) and as amended from time to time. 

  
 All other terms and conditions in this Agreement shall remain in full force and effect. 
  
 The foregoing amendment shall be effective as of the date first written above. 

 If you agree with the foregoing, please execute this agreement in the space provided below. 
  
 Sincerely, 
  
 MDS Nordion 
  

							
	Per:	  	 /s/ Gerry Vantellingen

	  	 	  	 
	Name:	  	Gerry Vantellingen	  	 	  	 
	Title:	  	Vice President, Sales	  	 	  	 
			
	 	  	 	  	We agree this 22nd day of December,
2004.
			
	 	  	 	  	Boston Life Sciences Inc.
				
	 	  	 	  	Per:	  	 /s/ Mark Pykett

	 	  	 	  	 	  	Mark Pykett

							
	 QUOTATION
 PRO-FORMA
INVOICE
	  	FROM: MDS NORDION
				
	TO:	  	Boston Life Science Inc.	  	 DATE:
	  	2004 December 22
	 	  	20 Newbury Street	  	 	  	 
	 	  	4th Floor	  	 OUR REFERENCE:
	  	2004-RQ-0400
	 	  	Boston, MA	  	 	  	 
	 	  	02116 USA	  	 YOUR REFERENCE:
	  	 
	Attention: Mr. Richard Thorn	  	 	  	 

  

					
	 ITEM

	  	 DESCRIPTION

	1.0	  	QUOTATION FOR THE SUPPLY OF BATCHES OF ALTROPANE
FROM JANUARY 1, 2005 UNTIL DECEMBER 31, 2005.
			
	 	  	Batch Description :	  	up to 20 shippable doses of Altropane (Note 1)
			
	 	  	Price :	  	 $[**] per dose for the first 15 doses.
 Minimum price per
Batch is $[**].
 Minimum monthly total is $[**] including Batches processed in that month.

			
	 	  	Freight Charges :	  	Prepaid and invoiced at cost. AirNet is recommended and is $160 per shipment.
		
	 	  	 Note:
  
 1.      An Altropane dose contains 5mCi of I-123 as of 18:00 hrs PT the day after manufacture.
Additional product specifications are as outlined in the Agreement between BLSI and MDS Nordion which expires on September 30, 2001.
  
 2.      Minimum two (2) business days notice to cancel a Batch.
  
 3.      Clinical
sites that are to receive an Altropane dose must have their orders in by Friday Noon (ET) prior to the week where a Batch is processed.
  

	
	 UNLESS OTHERWISE STATED, PRICES DO NOT INCLUDE ANY TAXES OR DUTY.
 THIS QUOTATION IS SUBJECT TO TERMS ON THE FACE AND SECOND PAGE.

			
	 SHIPPING SCHEDULE:
 As Requested By
Customer
	  	 DELIVERY:
 F.O.B. Vancouver,
BC

	 	  	 CURRENCY:
 United States
Dollars

	 TERMS (SEE SECOND PAGE):
 Net 30
Days
	  	 QUOTATION VALID UNTIL:
 2004
December 31

	 ISSUED ON BEHALF OF MDS NORDION:
                                        
             COLYN K. STEEVES, SALES, NUCLEAR MEDICINE

		
	 MDS Nordion
 Science
Advancing Health
	  	 447 March Road, P.O. Box 13500
 Kanata, Ontario,
Canada K2K 1X8
 Tel: (613) 592-2790    Fax: (613) 592-7638

 MDS Nordion 
 Science Advancing Health (letterhead) 
  
 January 24, 2005

  
 Boston Life Sciences Inc. 
 20 Newbury Street 
 Boston, Massachusetts 
 2116 USA 
  
 Dear Sirs: 
  

	Re:	Amendment #5 to Agreement between MDS Nordion Inc. 

 (now MDS Nordion, a division of MDS (Canada) Inc. 
 dated the 9th day of August, 2000 (the “Agreement”)

  
 Reference is made to the agreement between MDS Nordion Inc, (now MDS
Nordion, a division of MDS (Canada) Inc.) and Boston Life Sciences Inc. dated the 9th day of August 2000 (the
“Agreement”) and the letter dated December 22, 2004 RE: Amendment #4. 
  
 Part 2 is further amended to read as follow: 
  

	2.	In addition to the Maximum Batch Size available for purchase as identified in Section 4.1 of the Agreement, BLSI agrees to purchase and MDS Nordion agrees to supply Altropane under
the Agreement in accordance with the terms and Batch size appearing on the face of MDS Nordion’s Quotation 2004-RQ-0400A and as amended from time to time. The Terms and Conditions on the second page of the quotation shall not apply.

  
 All other terms and conditions in this Agreement shall remain in
full force and effect. 
  
 The foregoing amendment shall be effective as of the
date first written above. 
  
 If you agree with the foregoing, please execute this
agreement in the space provided below. 
  
 Sincerely, 
  
 MDS Nordion 
  
 We agree this 24th day of January, 2005. 
  
 Boston Life Sciences Inc. 
  

							
	Per:	 	 /s/ Gerry Vantellingen

	 	        Per:	 	 /s/ Mark Pykett

	Name:	 	Gerry Vantellingen	 	 	 	Mark Pykett
	Title:	 	Vice President, Sales	 	 	 	 

							
	 QUOTATION
 PRO-FORMA
INVOICE
	  	FROM: MDS NORDION
				
	TO:	  	Boston Life Science Inc.	  	 DATE:
	  	2005 January 11
	 	  	20 Newbury Street	  	 	  	 
	 	  	8th Floor	  	 OUR REFERENCE:
	  	2004-RQ-0400 “A”
	 	  	Boston, MA	  	 	  	 
	 	  	02116 USA	  	 YOUR REFERENCE:
	  	 
	Attention: Mr. Richard Thorn	  	 	  	 

  

					
	 ITEM

	  	 DESCRIPTION

	1.0	  	 QUOTATION FOR THE SUPPLY OF BATCHES
OF ALTROPANE FROM JANUARY 1, 2005 UNTIL DECEMBER 31, 2005.
  
 REVISION “A” ISSUED TO UPDATE THE AGREEMENT FOR YEAr 2005.

			
	 	  	Batch Description :	  	up to 20 shippable doses of Altropane (Note 1)
			
	 	  	Price :	  	 $[**] per dose for the first 15 doses.
 Minimum price per
Batch is $[**].
 Minimum monthly total is $[**] including Batches processed in that month.

			
	 	  	Freight Charges :	  	Prepaid and invoiced at cost. AirNet is recommended and is $160 per shipment.
		
	 	  	 Notes:
  
 1.      An Altropane dose contains 5 mCi of I-123 as of 15:00 hrs PT., the day after manufacture.
Additional product specifications are as outlined in the Agreement between BLSI and MDS Nordion which expires on December 31, 2005.

	
	 UNLESS OTHERWISE STATED, PRICES DO NOT INCLUDE ANY TAXES OR DUTY.
 THIS QUOTATION IS SUBJECT TO TERMS ON THE FACE AND SECOND PAGE.

			
	 SHIPPING SCHEDULE:
 As Requested By
Customer
	  	 DELIVERY:
 F.O.B. Vancouver,
BC

	 	  	 CURRENCY:
 United States
Dollars

	 TERMS (SEE SECOND PAGE):
 Net 30
Days
	  	 QUOTATION VALID UNTIL:
 2005
February 28

	 ISSUED ON BEHALF OF MDS NORDION:
                                        
             COLYN K. STEEVES, SALES, NUCLEAR MEDICINE

		
	 MDS Nordion
 Science
Advancing Health
	  	 447 March Road, P.O. Box 13500
 Kanata, Ontario,
Canada K2K 1X8
 Tel: (613) 592-2790    Fax: (613) 592-7638Employment Agreement of Henry Houston

 Exhibit 10.2 
  
 EMPLOYMENT AGREEMENT 
  

THIS AGREEMENT is made and entered into this 15th day of October, 2002, between D. HENRY HOUSTON (hereinafter referred to as “Employee”) and VARITEK INDUSTRIES, INC., a Texas corporation, by and through its Board of
Directors (hereinafter referred to as “Employer”, “Company”, or “Varitek”). 
  
 IN CONSIDERATION of the mutual promises set forth below, Employee and Employer hereby agree as follows: 
  
 1. Employment. Employer hereby agrees to employ Employee and Employee
hereby agrees to provide services to Employer in the position of VICE PRESIDENT and CHIEF FINANCIAL OFFICER upon the terms and conditions hereinafter set forth. 
  

2. Duties. Employee shall perform the duties and responsibilities set forth in Exhibit ”A” during the term of this Agreement. Employer
and Employee agree that Employee will be nominated to serve as a full voting member of the Board of Directors of Employer during the term of his employment and thereafter so long as he is re-elected by the then voting shareholders of the Company.

  
 3. Term of Agreement. The parties agree that the
initial term of this Agreement shall be three (3) years commencing October 15, 2002 (each year being referred to herein as a “Contract Year”), in addition Employee shall have the option, in Employee’s sole discretion, subject to the
provisions regarding termination set forth in this Agreement, to extend and renew this Agreement twice, for one (1) additional Contract Year (as defined herein) period per renewal. Such renewals shall become automatically effective so long as
Employee has not provided Employer with written notice of Employee’s intention to terminate. In the event Employee intends to not renew this Agreement, then Employee shall be required to provide written notice of termination no less than 60
days in advance of the expiration date of the then current Contract Year. 
  
 4. Termination. Should Employer terminate this Agreement and Employee’s employment for any reason other than for Cause as defined herein, and/or breach of any material provisions of this Agreement, and
further excluding the case in which Employee shall resign in the absence of Employer’s breach, Employer shall within thirty (30) days thereafter (“Severance Payment Date”) tender to Employee a lump sum cash payment equal to: (A)
Employee’s then current wages and projected bonus for the remainder of the current Contract Year plus, (B) an amount equal to the total compensation that would have been due for the following full Contract Year including any and all benefits,
projected bonuses, vacation pay, and incentives in place at the time of such termination. On the first anniversary of the Severance Payment Date, the Employer shall pay a sum equal to the present value (10% discount rate) of the balance due based on
the full value for the remainder of the existing term of this Agreement including all extensions available to Employee hereunder, plus an amount equal to all taxes, penalties, or assessments of any nature that Employee shall incur in connection with
such lump sum payment as described in Section 11. The amount of such tax payment shall be computed by a reputable un-conflicted accounting firm selected by Employee and paid for by the Company. In addition, at the time of such termination, all
unvested options shall become fully vested and exercisable pursuant to the terms of the Employee Stock Option Agreement attached hereto as Exhibit ”B”, and as it may be amended from time to time during the term of this Agreement.

  

 1 

 Notwithstanding any contrary provision set forth hereinabove, Employer shall have the right, at its
option, to terminate this Agreement for Cause as defined herein, provided, however, that prior to terminating Employee for Clause, Employer shall give Employee at least sixty (60) business days’ written notice of an intent to terminate for
Cause, which notice shall specify the nature and detail of such Cause, and, if Employee cures such Cause within such sixty (60) day period, this Agreement shall remain in full force and effect. 
  
 Employer may also terminate the employment of Employee hereunder upon the
death of Employee or upon Employee’s inability by reason of sickness or disability to perform his obligations for a period of more than one hundred eighty (180) days consecutively without payment of the lump sum described above, however upon
such termination, the Company shall exercise every reasonable effort to insure that Employee’s vesting schedule for any and all unvested options for shares of Employer’s stock shall be immediately accelerated so that all unvested options
shall become fully vested at the time of such termination. 
  
 Notwithstanding any contrary provisions set forth hereinabove, the Employee agrees that until such time as the Employer is generating positive earnings before interest, taxes, depreciation and amortization (EBITDA) for an entire fiscal year
period, upon termination without cause or should the Employee terminate his employment for good reason, the Employee shall be entitled solely to receive 12 months of wages based on the current wage amount plus projected bonuses for the follow on
12-month period as projected, plus he will be allowed to maintain any existing benefits provided pursuant to this Agreement for as long as legally possible, not to exceed one year, plus all of his options granted pursuant to Exhibit ”B”
shall immediately vest upon such event. 
  
 Employee may terminate
his employment hereunder for Good Reason as defined herein, upon at least thirty (30) days’ prior written notice to Employer, which notice shall specify the Good Reason, provided that if Employer cures such Good Reason within such thirty (30)
day period, this Agreement shall remain in full force and effect. In the event of a termination by Employee with Good Reason as aforesaid, the severance payments and vesting of employee stock options as described above shall be due and paid as if
Employee had been terminated without cause. 
  
 5. Employee
Working Conditions. Employer agrees that, during the term of this Agreement, Employer: (1) shall treat Employee with respect and professional courtesy commensurate with Employee’s position; (2) shall provide, establish and maintain
reasonable working conditions for Employee and abide by all state, federal and local employment regulations and laws; (3) shall not, without the express written consent of Employee, alter or significantly reduce the duties and responsibilities
assigned to Employee as set forth in Exhibit ”A” to this Agreement; (4) shall not, without Employee’s express written consent, reduce or relocate the facilities and perquisites made available to Employee at the time this Agreement is
executed and as enhanced during the term of this Agreement; (5) shall not materially reduce the type or level of Employee benefits to which Employee is entitled at the time this Agreement is executed and as enhanced during the term of this
Agreement; and (6) shall allow Employee to 
  

 2 

 perform his duties from locations other than the Employer’s place of business. At such time as the parties mutually
agree to location of the corporate offices, Employee shall within a reasonable time thereafter arrange to be present at the corporate offices from time to time on a regular basis demonstrating a presence commensurate with his position. 

 
 6. Salary and Performance Bonuses: As consideration for
Employee’s services as set forth in Exhibit ”A” to this Agreement, Employee agrees to accept and Employer agrees to pay Employee an initial salary of One Hundred Seventy Thousand Dollars ($170,000) per year, to be paid
twice per month in twenty-four equal installments. The base salary will be reviewed immediately after the Employer raises additional capital of not less than $3.5 million after March 1, 2003. Additionally, Employee shall be entitled to annual review
and increase in annual salary commensurate with executives in a similar position of responsibility. As further consideration for Employee’s services, Employee shall be eligible to participate in the Profit Sharing Plan attached as Exhibit
”C”. 
  
 7. Expenses: In addition, Employer will
reimburse Employee for all reasonable expenses incurred in the course of performing services for Employer, including but not limited to travel and entertainment expenses. The CEO or COO of the Employer must approve any
expense in excess of $10,000. Upon execution of this Agreement, the Employee shall submit for approval his expenses incurred on behalf of the Employer to the date of this Agreement. 
  
 8. Common Stock Options. Subject to customary anti-dilution clauses, and as further consideration for Employee’s
services, upon execution of this Agreement, Employee shall receive options to acquire common stock of the Employer in accordance with the following schedule: three hundred thousand (300,000) options to purchase the common stock of the Company, with
a two year vesting period with one hundred thousand (100,000) options vesting immediately and an additional 100,000 options vesting on each anniversary until all options are fully vested; provided, however, that the vesting schedule shall
immediately accelerate with all options being fully vested if this Agreement shall terminate for reasons other than Employee’s termination by the Company for Cause or Employee’s resignation, where such resignation occurs in the absence of
Good Reason or Employer’s breach of this Agreement. In the case of a termination with Cause, or an Employee resignation without Good Reason, the Option Agreement shall instead provide for vesting only through the date of termination and upon
termination, an exercise period of ninety (90) days thereafter shall apply. The exercise price of all stock options granted under this Agreement shall be $1.00 per share. Said stock options shall be granted pursuant to a Stock Option Plan. The Stock
Option Grant Agreement shall be attached to this Agreement as Exhibit ”B”. 
  
 9. Acceleration of Options. In addition to the provisions for acceleration set forth in paragraphs 8 and 14, upon the occurrence of any of the following events at a time while Employee holds outstanding options
or is entitled to future options to purchase Company Stock, the Company shall take whatever measures are necessary to insure that all such options shall be immediately vested and exercisable in full: 
  
 (i) the acquisition described in clause (i) of the
definition of Change of Control; 
  

 3 

  
 (ii) the
change in the composition of the Board of Directors described in clause (ii) of such definition; 
  
 (iii) the shareholder approval or adoption described in clauses (iii) or (iv) of such definition; 
  
 (iv) the commencement date of any tender offer subject to
the terms of Section 14(d)(1) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or exchange offer subject to the terms of the Securities Act of 1933, as amended (the “Securities Act”), or any other offer or
series of offers to purchase for cash, or to exchange for securities of a person other than the Company or any of its affiliates, Varitek Common Stock by any “person” or “group” of persons (as such terms are used in Rule 13d of
the Exchange Act) other than an offer or offers by Varitek or by employee benefit plan(s) sponsored by Varitek (“Tender Offer”) if such person or group would hold 30% or more of the then outstanding Varitek Common Stock after the
consummation of the Tender Offer. 
  
 10. Benefits.
Employee shall be provided health and welfare benefits including but not limited to medical (Employee and family), dental (Employee and family), disability and life insurance and vacation and sick leave on the same terms and conditions as similarly
situated senior executive level employees. Long-term disability insurance shall be fully paid during all periods of eligibility requiring premium. Employee shall be eligible to participate in any Employer provided 401(k) plans on the same terms and
conditions as Randy Bayne or the most senior executive officer of the company. In addition, Employee shall be entitled to qualify for and participate in all other Employer benefit plans, bonus programs and stock option programs, if any, in
accordance with the terms of such plans and programs. Employee will also be provided other benefits as described by exhibit hereto. 
  
 11. Gross-Up of Parachute Payments 
  
 (a) To provide Employee with adequate protection in connection with Employee’s ongoing employment with the Company, this Agreement or
other incentive plans of the Company provide Employee with various benefits in the event of termination of Employee’s employment with the Company pursuant to Section 4, or during the Protected Period. If Employee’s employment is terminated
in connection with a “change of control” of the Company, within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”), then a portion of those benefits could be characterized as “excess
parachute payments” within the meaning of Section 280G of the Code. The parties hereto acknowledge that the protections set forth in this Section 11 are important, and it is agreed that Employee should not have to bear the burden of the excise
tax that might be levied under Section 4999 of the Code or any similar provision of state or federal law, in the event that any portion of the benefits payable to Employee pursuant to this Agreement or the other incentive plans of the Company are
treated as an excess parachute payment. The parties, therefore, have agreed as set forth in this Section 11. 
  
 (b) Anything in this Agreement to the contrary notwithstanding, if it shall be determined that any payment or distribution (including
income recognized by Employee 
  

 4 

 upon the early vesting of restricted property or upon the exercise of options whose exercise date has
been accelerated) by the Company or any other person to, or for the benefit of Employee (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, but determined without regard to any additional
payments required under this Section 11) (a “Payment”) would be subject to the excise tax imposed by Section 4999 of the Code or any similar provision of state or federal law or any interest or penalties are incurred by Employee with
respect to such excise tax (such excise tax, together with any such interest and penalties, are hereinafter collectively referred to as the “Excise Tax”), then the Company shall pay an additional payment (a “Gross-Up Payment”),
in an amount such that after payment by Employee of all taxes (including any interest or penalties imposed with respect to such taxes), including, without limitation, any income taxes (and any interest and penalties imposed with respect thereto) and
Excise Tax imposed on the Gross-Up Payment, Employee retains an amount of the Gross-Up Payment equal to one hundred percent (100%) of the Excise Tax imposed on the Payments. 
  
 (c) In the event of any dispute as to the applicability or amount of any Gross-Up Payment, all
determinations required to be made under this Section 11, including whether and when a Gross-Up Payment is required and the amount of such Gross-Up Payment and the assumptions to be utilized in arriving at such determination, shall be made by the
independent public accounting firm regularly employed by the Company (the “Accounting Firm”) which shall provide detailed supporting calculations both to the Company and to Employee within 15 business days after the receipt of notice from
Employee that there has been a Payment, or such earlier time as is requested by the Company. All fees and expenses of the Accounting Firm will be borne by the Company. If the Accounting Firm determines that no Excise Tax is payable by Employee, it
shall furnish Employee with a written statement that failure to report the Excise Tax on Employee’s applicable federal income tax return would not result in the imposition of a negligence or similar penalty. Any determination by the Accounting
Firm shall be binding on the Company and Employee unless and until a final determination is received from the Internal Revenue Service indicating a contrary result. As a result of uncertainty in the application of Section 4999 of the Code at the
time of the initial determination by the Accounting Firm hereunder, it is possible that Gross-Up Payments may not have been made by the Company that should have been made (“Underpayment”), consistent with the calculations required to be
made hereunder. If the Employee thereafter is required to make a payment of any Excise Tax, the Accounting Firm shall determine the amount of the Underpayment that has occurred and the Company to or for the benefit of Employee shall promptly pay any
such Underpayment, consistent with the maximum limitation stated in paragraph 11(b) above. In the event it is determined by the Accounting Firm that the Gross Payments previously made by the Company exceeded the limitations stated in paragraph 11(b)
above, upon written notice from the Company, accompanied by a copy of the Accounting Firm’s calculation of same, the amount of such overpayment shall be promptly paid by the Employee to the Company. 
  
 12. Salary/Bonus Deferral. Employer may request Employee to defer
payment and receipt of a portion of salary and bonuses due to Employee for a period of not more than six (6) months from the date this Agreement is executed, provided Employer agrees to pay, a.) that 
  

 5 

 portion of the deferred compensation necessary to pay any and all taxes on the deferred amount plus, b.) reasonable
interest on the deferred amount, both a) and b) are as determined by Employee’s accountant, and provided that deferrals shall be limited as follows. Employee’s gross monthly income excluding the tax payment for the deferred amount shall
not be less than Ten Thousand and 00/100 Dollars ($10,000.00) as a result of the deferral. 
  
 13. Other Interests. In addition, during the term of this Agreement, Employee shall be allowed to pursue other business interests and/or professional pursuits, provided that Employee’s pursuit of other
business interests shall not materially diminish Employee’s performance of his duties as set forth herein. 
  
 14. Termination Due To Disability. In the event Employee becomes permanently disabled and Employee’s physician determines Employee is unable
to perform his regular or customary duties as a result of the disability (and the Employer is unable to reasonably accommodate Employee’s disability), Employer agrees to pay Employee’s then current compensation for a six-month period or
until such time as Employee’s long term disability insurance benefits in an amount not less than sixty percent (60%) of his then-current salary shall commence. In addition, upon such termination, the Company will exercise every reasonable
effort to cause Employee’s vesting schedule for any and all unvested options granted herein for shares of Employer’s stock to be immediately accelerated such that all unvested options shall become fully vested at the time of such
termination. 
  
 15. Health and Welfare. As further
consideration for Employee’s services, Employer agrees to provide after termination of this Agreement and at the Employer’s expense, health and welfare insurance benefits to Employee under the same terms and conditions as provided to
Employee during the term of this Agreement to the maximum extent allowed by COBRA. Employee’s benefits shall also include a life insurance policy in a death benefit amount of not less than One Million ($1,000,000) naming Dana
Houston, or such other parties as Employee may designate from time to time, as beneficiary; also remaining in effect for the period of time COBRA health insurance benefits continue. 
  
 16. No Mitigation Obligation. The Company acknowledges that it will be
difficult and may be impossible (i) for Employee to find reasonably comparable employment following termination of Employee’s employment and (ii) to measure the amount of damages which Employee may suffer as a result of the termination of
Employee’s employment. Accordingly, all amounts paid to Employee under this Agreement following Employee’s termination of employment are acknowledged by the Company to be reasonable and to be liquidated damages, and Employee will not be
required to mitigate the amount of such payments by seeking other employment or otherwise, nor will any profits, income, earnings or other benefits from any source whatsoever (including from other employment) create any mitigation, offset, reduction
or any other obligation on the part of Employee under this Agreement. 
  
 17. Trade Secrets. Employee will, in the course of his duties on behalf of Employer, be advised of certain business matters and affairs of Employer regarding its clients and the management of its business. The duties performed by
Employee for Employer place him in a position of trust and confidence with respect to certain trade secrets relating to the business of 
  

 6 

 Employer and not generally known to the public. Employee will not, either during the term of his employment or any time
in the future, directly or indirectly: 
  
 (a)
disclose or furnish, directly or indirectly, to any other person, firm, agency, corporation, client, business, or enterprise, any trade secrets acquired by him during the term of this Agreement except in confidence in the ordinary course of the
Company’s business where appropriate to serve the interests of the Company. 
  
 (b) individually or in conjunction with any other person, firm, agency, company, client, business, or corporation, employ or cause to be
employed any trade secret in any manner whatsoever, except in furtherance of the business of Employer. 
  
 Notwithstanding any contrary provision set forth hereinabove, and without limiting the scope of the covenants made by Employee in this Paragraph 17,
Employee agrees that Employee shall, from time to time, subscribe to and execute agreements with the Company in the form and content subscribed to and executed by other employees of the Company to protect the Company’s trade secrets and
proprietary information. 
  
 18. Corporate Authority.
Employer acknowledges and agrees that Employer has the full authorization of its Board of Directors to enter into and perform all aspects of this Agreement from and after the date it is executed. 
  
 19. Breach. Each party to this Agreement shall indemnify and hold the
other harmless for any and all losses, costs, damages, expenses, (including attorneys’ fees) incurred by the indemnified party arising out of such party’s breach of this Agreement or any part thereof, regardless of the judgment or
decisions arising therefrom. All such losses, costs, damages, expenses and fees shall be paid within thirty (30) days following tender of a written request. The provisions of this Section 19 will survive the term of this Agreement, and termination
of Employee’s employment for any reason whatsoever. 
  
 20.
Policies. No change in Employer policy, rules or regulations shall alter, modify or revoke any provision of this Employment Agreement to the detriment of Employee. 
  
 21. Indemnity and Hold Harmless. To the fullest extent provided by the law, Employer agrees Employer shall indemnify
and hold Employee harmless from any and all liabilities and/or losses, costs, damages or expenses, (including attorney’s fees) incurred by Employee in the course and scope of Employee’s duties for Employer or related in any way to
Employee’s association with Employer as an employee, officer and/or director, including but not limited to, liabilities arising from shareholder derivative or direct law suits. Employer shall fully insure Employer’s ability to so indemnify
Employee and shall present evidence of such insurance coverage reasonably satisfactory to Employee within thirty (30) days of the execution of this Agreement and from time to time thereafter as may be reasonably requested by Employee. The
provisions of this Section 21 will survive the Term of this Agreement, and termination of Employee’s employment for any reason whatsoever. 
  
 22. Successors. This Agreement shall be binding upon, and shall inure to the benefit of, the parties hereto and their respective heirs, legal
representatives, successors and permitted assigns. 
  

 7 

 23. Assignment. This Agreement is personal to Employee, and Employee shall not, outside the normal
course of business, assign any of Employee’s rights or delegate any of Employee’s duties hereunder without the prior written consent of the Company. Neither Employee nor Employee’s spouse will have the right to commute, encumber, or
otherwise dispose of any future payments due under this Agreement. The Company shall have the right to assign this Agreement to a successor in interest in connection with a merger, sale of substantially all assets, or the like; provided however,
that an assignment of this Agreement to an entity with operations, products or services outside of the industries in which the Company is then active shall not be deemed to expand the scope of Employee’s covenant not to compete with such
operations, products or services without Employee’s written consent. The Company shall require any Person who is the successor (whether direct or indirect, by purchase, merger, consolidation, reorganization, or otherwise) to all or
substantially all of the business and/or assets of the Company to expressly assume and agree to perform, by a written agreement in form and substance reasonably satisfactory to Employee, all of the obligations of the Company under this Agreement. As
used in this Agreement, the term “Company” means the Company as defined herein and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, written agreement, or
otherwise. 
  
 24. Severability. Employer and Employee
agree that should any provision of this Agreement be declared or be determined by any court of competent jurisdiction to be illegal, invalid or unenforceable, the legality, validity and enforceability of the remaining parts, terms and provisions
shall not be affected thereby, and said illegal, unenforceable or invalid part, term or provision will be deemed not to be part of this Agreement. 
  
 25. Confidentiality. Employee and Employer agree that they shall keep the terms of this Agreement entirely confidential, except as and to the
extent required to be disclosed by applicable law, code or regulation. 
  
 26. Jurisdiction and Venue. This Agreement shall be governed by and interpreted in accordance with the laws of the State of Texas. The parties agree that any claim or action arising out of this Agreement shall be arbitrated in
accordance with the arbitration provisions and guidelines set forth on Exhibit ”D” attached hereto and incorporated herein by this reference. The parties anticipate that all disputes hereunder shall be arbitrated; provided, however, that
any matter not subject to arbitration as a matter of law shall be brought in a court of competent jurisdiction in the county and judicial district in which the principal offices of the Company are located at the time the action is commenced.

  
 27. Entire Understanding. This Agreement contains all
the understandings and agreements between the parties concerning Employee’s employment. This Agreement replaces any and all prior agreements between Employee and Employer related to Employee’s employment and any and all such prior
Agreements are hereby canceled. 
  
 28. Attorney’s Fees
Reimbursement. Employer agrees to reimburse Employee for Employee’s reasonable attorney fees incurred by Employee in connection with the negotiation, interpretation, arbitration and/or execution of this Agreement. 
  

 8 

 29. Definitions: 
  
 (a) Cause: When used in connection with the termination of employment with the Company, means the
termination of Employee’s employment by the Company by reason of (i) the conviction of Employee of a crime involving a felony by a court of competent jurisdiction as to which no further appeal can be taken; (ii) the proven commission by
Employee of an act of fraud upon the Company; (iii) the willful and proven misappropriation of any funds or property of the Company by Employee; (iv) the willful, continued and unreasonable failure by Employee to perform material duties assigned to
Employee and agreed to by Employee after reasonable notice and opportunity to cure such performance; (v) the knowing engagement by Employee in any direct, material conflict of interest with the Company and which is a specific violation of the
Company’s conflict of interest policy, if any, then in effect; (vi) the knowing engagement by Employee, without the written approval of the Board of Directors of the Company, in any activity which directly competes with the business of the
Company or any of its Affiliates or which would result in material injury to the Company; or (vii) the knowing engagement in any activity which would constitute a material violation of the provisions of the Company’s Insider Trading Policy or
Business Ethics Policy, if any, then in effect. 
  
 (b) Change of Control : means: 
  
 (i) The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act (a “Designated Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the
Securities Exchange Act of 1934, as amended, (the “Exchange Act”)) of 30% or more of either: (1) the then outstanding shares of Common Stock of Varitek (the “Outstanding Varitek Common Stock”) or (2) the combined voting power of
the then outstanding voting securities of Varitek entitled to vote generally in the election of directors (the “Outstanding Varitek Voting Securities”); provided, however, that the following acquisitions shall not constitute a Change in
Control if, (i) any acquisition of Common Stock of Varitek or Outstanding Varitek Voting Securities directly from Varitek, (ii) any acquisition of Common Stock of Varitek or Outstanding Varitek Voting Securities by Varitek, (iii) any acquisition of
Common Stock of Varitek or voting securities of Varitek by any employee benefit plan(s) (or related trust(s)) sponsored or maintained by Varitek or any Outstanding Varitek Voting Securities by any corporation controlled by Varitek and approved by
the Incumbent Board, or (iv) any acquisition by any corporation pursuant to a reorganization, merger or consolidation, if, immediately following such reorganization, merger or consolidation, the conditions described in clauses (1), (2) and (3) of
paragraph (iii) of this definition are satisfied; or 
  
 (ii) individuals who, as of the date hereof, constitute the entire Board of Directors of Varitek (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board of Directors of Varitek (the “Board
“); provided, however, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by Varitek shareholders, was approved 
  

 9 

 by a vote of at least a majority of the directors then comprising the Incumbent Board (including, without
limitation, the proposed Board members, plus the slot designated for the chairman of the audit committee to be elected at our next meeting of shareholders) shall be considered as though such individual were a member of the Incumbent Board, but
excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either (1) an actual or threatened election contest (as such terms are used in Rule l4a-1 1 of the Regulation 14A promulgated under the
Exchange Act), or an actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board or (2) a plan or agreement to replace a majority of the members of the Board then comprising the Incumbent Board; or

  
 (iii) approval by the shareholders of Varitek
of a reorganization, merger or consolidation, in each case unless, immediately following such reorganization, merger or consolidation, (1) more than 60% (or such greater percentage as may be approved by the Incumbent Board) of the then outstanding
shares of common stock of the corporation resulting from such reorganization, merger or consolidation (including, without limitation, a corporation which as a result of such transaction owns Varitek through one or more subsidiaries) and the combined
voting power of the then outstanding voting securities of such corporation entitled to vote generally in the election of directors is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who
were the beneficial owners, respectively, of the Outstanding Varitek Common Stock and Outstanding Varitek Voting Securities immediately prior to such reorganization, merger or consolidation in substantially the same proportions as their ownership
immediately prior to such reorganization, merger or consolidation, of the Outstanding Varitek Common Stock or Outstanding Varitek Voting Securities, as the case may be, (2) no Designated Person (excluding Varitek, any employee benefit plan(s) (or
related trust(s)) of Varitek and/or its subsidiaries or any Person beneficially owning, immediately prior to such reorganization, merger or consolidation, directly or indirectly, 30% (or such lesser percentage as may be approved by the Incumbent
Board) or more of the Outstanding Varitek Common Stock or Outstanding Varitek Voting Securities, as the case may be) beneficially owns, directly or indirectly, 30% (or such lesser percentage as may be approved by the Incumbent Board) or more of,
respectively, the then outstanding shares of common stock of the corporation resulting from such reorganization, merger or consolidation or the combined voting power of the then outstanding voting securities of such corporation entitled to vote
generally in the election of directors, and (3) at least a majority of the members of the board of directors of the corporation resulting from such reorganization, merger or consolidation were members of the Incumbent Board at the time of the
execution of the initial agreement providing for such reorganization, merger or consolidation; or 
  
 (iv) approval by the shareholders of the Varitek of: (1) a complete liquidation or dissolution of Varitek or (2) the sale or other
disposition of all or substantially all of the assets of Varitek, other than to a corporation, with respect 
  

 10 

 to which immediately following such sale or other disposition, (A) more than 60% (or such greater
percentage as may be approved by the Incumbent Board) of the then outstanding shares of common stock of such corporation and the combined voting power of the then outstanding voting securities of such corporation entitled to vote generally in the
election of directors is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were beneficial owners, respectively, of the Outstanding Varitek Common Stock and Outstanding Varitek Voting
Securities immediately prior to such sale or other disposition in substantially the same proportion as their ownership, immediately prior to such sale or other disposition, of the Outstanding Varitek Common Stock and Outstanding Varitek Voting
Securities, as the case may be, (B) no Designated Person (excluding the Varitek and any employee benefit plan (or related trust) of Varitek and/or its subsidiaries or such corporation and any Person beneficially owning, immediately prior to such
sale or other disposition, directly or indirectly, 30% (or such lesser percentage as may be approved by the Incumbent Board) or more of the Outstanding Varitek Stock or Outstanding Varitek Voting Securities, as the case may be) beneficially owns,
directly or indirectly, 30% (or such lesser percentage as may be approved by the Incumbent Board) or more of, respectively, the then outstanding shares of common stock of such corporation or the combined voting power of the then outstanding voting
securities of such corporation entitled to vote generally in the election of directors, and (C) at least a majority of the members of the board of directors of such corporation were members of the Incumbent Board at the time of the execution of the
initial agreement or action of the Board providing for such sale or other disposition of assets of Varitek. 
  
 (c) Confidential Information: includes information conveyed or assigned to the Company by Employee or conceived, compiled, created,
developed, discovered or obtained by Employee from and during his employment relationship with the Company, whether solely by Employee or jointly with others, which concerns the affairs of the Company or its Affiliates and which the Company could
reasonably be expected to desire be held in confidence, or the disclosure of which would likely be embarrassing, detrimental or disadvantageous to the Company or its Affiliates and without limiting the generality of the foregoing includes
information relating to inventions, and the trade secrets, technologies, products, services, finances, business plans, marketing plans, legal affairs, supplier lists, client lists, potential clients, business prospects, business opportunities,
personnel assignments, contracts and assets of the Company or any of its Affiliates and information made available to the Company or any of its Affiliates by other parties under a confidential relationship. Confidential Information, however, shall
not include information (a) which is, at the time in question, in the public domain through no wrongful act of Employee, (b) which is later disclosed to Employee by one not under obligations of confidentiality to the Company or any of its Affiliates
or Employee, (c) which is required by court or governmental order, law or regulation to be disclosed, or (d) which the Company has expressly given Employee the right to disclose pursuant to written agreement. 
  

 11 

 (d) Contract Year: shall mean during the term of employment, each year of the
Employee’s employment with the company beginning on the anniversary date of execution of this Employment Agreement and continuing 365 days thereafter, ending on that day which is immediately preceding the execution anniversary date for the
following year.  
  
 (e) Good
Reason: means the occurrence of any of the following events: 
  
 (i) Employee is assigned any duties materially inconsistent with, or diminished from, Employee’s positions, duties, responsibilities and status with the Company immediately prior to the commencement of the
Protected Period, or Employee’s status, reporting responsibilities, titles or offices are materially diminished from those in effect immediately prior to the commencement of the Protected Period, or Employee is removed from or is not re-elected
or appointed to any of such responsibilities, titles, offices or positions, or Employee’s duties and responsibilities are materially increased without a corresponding increase in the Employee’s compensation (such increase in compensation
to be satisfactory to Employee, in Employee’s sole reasonable judgment), except in each case in connection with the termination of Employee’s employment by the Company for Cause or on account of disability, or as a result of the
Employee’s death, or by the Employee for other than Good Reason; or 
  
 (ii) Employee’s Annual Base Salary is reduced from that in effect immediately prior to the commencement of the Protected Period or as the same may be increased from time to time thereafter; or 
  
 (iii) The Company fails to continue in effect any benefit or
compensation plan, including, but not limited to, the annual bonus plan, qualified retirement plan, executive life insurance plan and/or health and accident plan, in which Employee is participating immediately prior to the commencement of the
Protected Period, or plans providing, in the sole reasonable judgment of Employee, Employee with substantially similar benefits, or the Company takes any action that would adversely affect Employee’s participation in or reduce Employee’s
benefits or compensation under any of such plans (excluding any such action by the Company that is required by law); or 
  
 (iv) The Company’s principal executive offices are relocated at any time following a Change in Control more than 20 miles from where
such offices were located immediately prior to such Change in Control; or 
  
 (v) The Company requires Employee at any time following a Change in Control to relocate more than 20 miles from where Employee’s office was located immediately prior to such Change in Control; or 
  
 (vi) The amendment, modification or repeal of any provision
of the Certificate of Incorporation or Bylaws of the Company that was in effect immediately prior to the commencement of the Protected Period, if such amendment, modification or repeal would materially adversely affect Employee’s rights to
indemnification by the Company; or 
  

 12 

 (vii) The Company shall violate or breach any obligation of the Company in effect
immediately prior to the commencement of the Protected Period (regardless whether such obligation be set forth in the Bylaws of the Company and/or in this Agreement or any other separate agreement entered into between the Company and Employee) to
indemnify Employee against any claim, loss, expense or liability sustained or incurred by Employee by reason, in whole or in part, of the fact that Employee is or was an officer or director of the Company; or 
  
 (viii) The Company shall violate or breach any other
material obligation of the Company owing to Employee in effect immediately prior to the commencement of the Protected Period relating to Employee’s employment with the Company, but only if such violation or breach (if capable of being remedied)
shall continue unremedied for more than 15 days after written notice thereof is given by Employee to the Company; or 
  
 (ix) The Board (or any nominating committee of the Board) fails to recommend and support Employee’s re-election as a director of the
Company if the Employee is a director of the Company immediately prior to the commencement of the Protected Period; or 
  
 (x) The Company shall fail to keep in force, for the benefit of Employee, directors’ and officers’ insurance policy with
coverage amounts and scope equal to the coverage amounts and scope under such policy immediately prior to the commencement of the Protected Period; or 
  
 (xi) The Company fails to obtain from a successor (including a successor to a material portion of the business or assets of the Company a
satisfactory assumption in writing of the Company’s obligations under this Agreement; or 
  
 (xii) The Company fails to provide Employee with office space, related facilities and support personnel (including, but not limited to,
administrative and secretarial assistance) that are both commensurate with the Employee’s position and Employee’s responsibilities to and position with the Company immediately prior to the Change of Control and not materially dissimilar to
the office space, related facilities and support personnel provided to other executive officers of the Company or executive officers of similar stature in other businesses; or 
  
 (xiii) The Company notifies Employee of the Company’s intention not to observe or perform one or more
of the obligations of the Company under this Agreement. 
  

 13 

 IN WITNESS WHEREOF the parties have executed this Agreement the day and year first written above at
Houston, Texas. 
  

			
	 EMPLOYEE:
	 	 
		
	 /s/ D. Henry Houston

	 	 
	 D. Henry Houston
	 	 
		
	 Notices in Care of:
	 	 D. Henry Houston
  

	 	 	  

		
	 And to:
	 	Varitek Industries, Inc.
	 	 	Randy Bayne, President & CEO

  

			
	 VARITEK INDUSTRIES, INC.

	
	 /s/ Randy S. Bayne

	 By:
	 	Randy S. Bayne
	 Its:
	 	President and CEO

  

			
	 And to:
	    	Roger V. Davidson, Esq.
	 	    	Ballard, Spahr, Andrews & Ingersoll, LLP
	 	    	1225 17th Street, Suite 2300
	 	    	Denver, CO 80202

  

 14 

 Exhibit “A” 
  
 Duties of the Vice President and Chief Financial Officer 
  
 The Vice-President and Chief Financial Officer shall report directly to the CEO. The Chief Financial Officer shall be responsible for
carrying out the mandates of the CEO and the Board of Directors. The Chief Financial Officer shall manage, supervise and direct all of the activities of the Company relating to accounting, taxes, finance, human resources, legal and administration.
Further, there may be one or more Vice Presidents designated to assist the Chief Financial Officer in the performance of his duties. The Chief Financial Officer generally shall do or cause to be done all things necessary or proper in carrying out
the financial affairs of the Company in accordance with the provisions of applicable law, regulation and the mandates of the Board of Directors. 
  

 A-1 

 Exhibit “B” 
  
 VARITEK INDUSTRIES, INC. 
  
 STOCK OPTION GRANT NOTICE 
 UNDER THE
STOCK OPTION PLAN 
  
 Varitek Industries, Inc., a Texas
corporation (the “Company”), pursuant to its Stock Option Plan (the “Plan”), hereby grants to the Optionee named below an option to purchase the number of shares of the Company’s Common Stock set forth below. This option is
subject to all of the terms and conditions set forth herein and in Attachments I, II and III, which are incorporated herein in their entirety. If applicable, it is also subject to Optionee’s employment agreement. 
  

			
	 Optionee:
	  	Henry Houston
		
	 Date of Grant:
	  	October 15, 2002
	 Shares Subject to Option:
	  	300,000
	 Exercise Price Per Share:
	  	$1.00
	 Expiration Date:
	  	October 15, 2012

  

			
	 x Incentive Stock Option
	  	 ̈ Non-statutory Stock Option

  
 Vesting
Schedule: 
  
 This option shall vest and become exercisable
in the following installments based on the Optionee’s Continuous Status as an Employee over a two-year period commencing as of October 15, 2002: 
  

			
	 Number of Shares (Installment)

	  	 Date of Earliest Exercise (Vesting)

	 100,000
	  	October 15, 2002
	 100,000
	  	October 15, 2003
	 100,000
	  	October 15, 2004

  
 In addition, this
option shall become fully vested pursuant to the terms specified in Section 10(b) of the Plan. 
  
 Payment: Payment of the exercise price of the option upon exercise thereof shall be by cash or check or by delivery of previously owned shares of the Company’s Common Stock. 
  
 Additional Terms/Acknowledgments: The Optionee acknowledges receipt of, and understands and
agrees to, this Grant Notice, the Stock Option Agreement and the Plan. Optionee further acknowledges that as of the date of grant set forth above, this Grant Notice, the Stock Option Agreement and the Plan set forth the entire understanding between
the Optionee and the Company regarding the acquisition of stock in the Company and supersede all prior oral and 
  

 B-1 

 written agreements on that subject with the exception of (i) options previously granted and delivered to the Optionee
under the Plan, and (ii) the following agreements only: Other Agreements: 
  

	
	 
	
	 
	
	 

  

							
	 VARITEK INDUSTRIES, INC.
	 	HENRY HOUSTON:
	 a Texas corporation
	 	 	  	 
			
	 By:
	 	  

	 	

				
	 Title:
	 	  

	 	Printed Name:	  	  

				
	 Date Signed:
	 	                                      
                      ,
                        	 	Date Signed:	  	                                      
                      ,
                
	 	 	 	 	 	  	 

  
 Attachment I: Stock Option Agreement

 Attachment II: Stock Option Plan 
 Attachment III Notice of
Exercise 
  

 B-2 

 Exhibit “C” 
  
 Profit Sharing Pool Plan 
  
 This Profit Sharing Pool Plan (“Plan”) is being adopted to provide incentive compensation to Employer’s most highly-compensated executive
officers. Certain employees shall be eligible to participate in the Plan available for Employer’s senior executives, which shall be based on the financial performance of Employer as follows: 
  
 Level 1: If Employer reaches an annual sales level of $5
million, 10% of Employer’s total Net Profit before interest payments, taxes, depreciation and amortization (“EBITDA”) for such period shall be contributed to the pool. 
  
 Level 2: If Employer reaches an annual sales level of $10 million, 8% of Employer’s EBITDA for such
period shall be contributed to the pool. 
  
 Level 3: If Employer reaches an annual sales level of $20 million, 4% of Employer’s EBITDA for such period shall be contributed to the pool. 
  
 Level 4: If Employer reaches an annual sales level of $40 million, 2% of Employer’s EBITDA for such period shall be contributed to
the pool. 
  
 Level 5: If Employer reaches an
annual sales level of $80 million, 1% of Employer’s EBITDA for such period shall be contributed to the pool. 
  
 The sales levels and amounts of contributions referred to above shall be cumulative and determined in accordance with generally accepted accounting
principles consistently applied, except to the extent expressly provided otherwise herein. All milestone incentive package payments shall be determined and made annually based on the Employer’s results of operations for such fiscal year period,
as audited by the Employer’s independent certified public accountants and shall be payable within 30 days of the receipt of the audit report. 
  
 No compensation payments will be due to any participant under the Plan until Employer reaches the annual sales level referred to in Level 1. The total
pool shall in no case exceed the lesser of 10% of EBITDA or $2 million. Payments shall be made hereunder only to the extent determined to be financially feasible in the sole good faith discretion of Employer’s audit committee, which shall
consist of that number of independent directors as may be required by SEC rules or rules promulgated by any securities exchange or Nasdaq. 
  
 Each executive officer’s participation in the pool shall be based on the sole discretion of the Employer’s compensation committee.
Notwithstanding that, an employee’s participation may be negotiated as part of his or her employment agreement. If in the judgment of the members of the compensation committee, the Employer’s results for the year were impacted positively
by the extraordinary contribution of the employee, the employee’s percentage share of the pool may be increased at the sole discretion of the compensation committee. 
  

 C-1 

 Exhibit “D” 
  
 Arbitration Provisions and Guidelines 
  
 ARBITRATION AGREEMENT 
  
 A. Any dispute(s) or difference(s) which arise during the course of this Agreement and which either involve its interpretation or meaning, or relate to
performance required hereunder shall be submitted to and resolved by binding arbitration; provided, however, that the parties are not waiving and are expressly reserving their right to seek injunctive relief by judicial process. Nevertheless, the
parties may, by subsequent consent, agree to submit requests for injunctive relief to an arbitrator or arbitration panel. 
  
 B. If either party shall, in the opinion of the other party, be in breach of or default in the performance or observance of any term or condition of this
Agreement, the non-defaulting party shall notify the defaulting party in writing of such fact, and the defaulting party shall have thirty (30) days from the receipt of such notice to remedy or correct such breach or default. If the non-defaulting
party asserts that the breach of default has not been timely and properly cured, it may commence arbitration as described herein and ask the arbitrator to deem this Agreement terminated and/or to grant such relief as is shown to be appropriate.

  
 C. In the event the parties are unable to agree upon an
arbitrator to hear and resolve their differences (hereinafter the “Dispute”), each party shall designate one person licensed as an attorney in the state containing the headquarters of the Company. Said two attorneys shall select the
neutral arbitrator. Unless agreed upon by the parties to the contrary, arbitration shall be by a single, neutral arbitrator (hereinafter, the “Arbitrator”). 
  
 D. If the two attorneys designated in the immediately preceding paragraph cannot agree on the selection of the Arbitrator,
the matter of the selection of the Arbitrator shall be submitted to the presiding judge of the District Court for the jurisdictionally appropriate county in which the Company’s principal office is located. In such event, the selection shall be
limited to one person from a panel of retired judges, each party hereto submitting three names for the court to consider and from which the Arbitrator shall be selected. 
  
 E. The Arbitrator shall have the full and absolute authority to interpret this Agreement, to deem conduct by the parties as
either in compliance with or in breach of this Agreement, to terminate this Agreement, and (if a breach is found) to award appropriate damages or relief. 
  
 F. The Dispute shall be settled in accordance with then existing law of the state in which the Company’s headquarters are located. While evidence may
be accepted, omitted, considered or excluded in the discretion of the Arbitrator, the Arbitrator shall be bound by that state’s rules of evidence and by the application of that state’s uniform act, if any, governing arbitration. The final
decision of the Arbitrator shall be served on the parties, in writing, within 20 days after the conclusion of the arbitration hearing. 
  
 G. The Arbitrator’s decision shall be binding and conclusive. Neither party shall pursue, prosecute or otherwise file any legal action or proceeding
(other than to seek injunctive 
  

 D-1 

 relief as described above). Except as provided in the uniform act, if applicable, as provided above, no appeal shall be
taken from the Arbitrator’s decision or from any subsequent court order confirming said decision. 
  
 H. The parties shall equally advance the costs incurred by arbitration. The Arbitrator, however, shall have the discretion to award such costs as well as
attorneys’ fees to the party prevailing in the arbitration proceedings. 
  

 D-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}]]